Prime Only Members-Only Article

Spend the Money

|
May 17, 2022 5:11 p.m.
THE BACKCHANNEL
FREE EDITION
Your subscription could not be saved. Please try again.
Your subscription has been successful.
NEW!
A FREE email newsletter from Josh Marshall An email newsletter from Josh Marshall

Some of you likely have had similar experiences or know people who have. I continue to hear from people who got COVID, got fairly sick, then took the main antiviral, Paxlovid, and basically within a day or so went from bad flu to mild cold at worst. I just heard another story like this from a reader. To be clear, these weren’t people who were hospitalized. But the people who I’m talking about were, either because of age or health conditions, people who had heightened vulnerability to COVID. They were getting sick and then they got almost totally better very quickly. Probably most or all of them would have been fine. And in many cases they were just saved a miserable week or two. But as we know, a bad case of COVID can degenerate quickly.

This is a members-only article
Small Team. Big Results.
We’re proud of what our small newsroom has accomplished and it’s not hyperbole when we say that without our members, none of this would be possible.
Free memberships available for students and those experiencing financial hardship.
Already a member? SIGN IN
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: